[{"address1": "451 D Street", "address2": "5th Floor Suite 501", "city": "Boston", "state": "MA", "zip": "02210", "country": "United States", "phone": "857 209 0050", "website": "https://elicio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops a pipeline of novel immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph node\u0096targeted AMP peptide vaccine that is in Phase II clinical trial to target seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company is also developing ELI-007, a multivalent lymph node\u0096targeted AMP peptide vaccine to target mutant v-raf murine sarcoma viral oncogene homolog B1 gene mutations found in solid tumors; and ELI-008, a multivalent lymph node\u0096targeted AMP peptide vaccine to target p53 hotspot mutations. The company is headquartered in Boston, Massachusetts.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert T. Connelly", "age": 64, "title": "CEO, President, Principal Accounting Officer & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 678300, "exercisedValue": 0, "unexercisedValue": 239308}, {"maxAge": 1, "name": "Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D.", "age": 77, "title": "Founder & Independent Director", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 52520, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher M. Haqq M.D., Ph.D.", "age": 58, "title": "Executive VP, Head of Research & Development and Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 673821, "exercisedValue": 0, "unexercisedValue": 161616}, {"maxAge": 1, "name": "Dr. Darrell J. Irvine Ph.D.", "title": "Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Preetam  Shah M.B.A., Ph.D.", "age": 51, "title": "Chief Strategy & Financial Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  DiVecchia", "title": "Senior Vice President of Operations & Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  DeMuth Ph.D.", "age": 38, "title": "Chief Scientific Officer", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan C. Filoon", "title": "General Counsel, Secretary & Compliance Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Esther  Welkowsky", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Joy  Seymour", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 5.07, "open": 5.2876, "dayLow": 5.0, "dayHigh": 5.2876, "regularMarketPreviousClose": 5.07, "regularMarketOpen": 5.2876, "regularMarketDayLow": 5.0, "regularMarketDayHigh": 5.2876, "payoutRatio": 0.0, "forwardPE": -1.9455253, "volume": 19442, "regularMarketVolume": 19442, "averageVolume": 48015, "averageVolume10days": 57350, "averageDailyVolume10Day": 57350, "bid": 0.0, "ask": 5.04, "bidSize": 0, "askSize": 1, "marketCap": 79767504, "fiftyTwoWeekLow": 3.342, "fiftyTwoWeekHigh": 11.45, "fiftyDayAverage": 7.6469, "twoHundredDayAverage": 5.642355, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 64420924, "profitMargins": 0.0, "floatShares": 8577640, "sharesOutstanding": 15953500, "sharesShort": 170043, "sharesShortPriorMonth": 139856, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0107, "heldPercentInsiders": 0.43609002, "heldPercentInstitutions": 0.07116, "shortRatio": 4.71, "shortPercentOfFloat": 0.0123000005, "impliedSharesOutstanding": 16845100, "bookValue": -1.026, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -51898000, "trailingEps": -4.25, "forwardEps": -2.57, "lastSplitFactor": "1:10", "lastSplitDate": 1685664000, "enterpriseToEbitda": -1.442, "52WeekChange": -0.4582882, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 5.0, "targetHighPrice": 12.0, "targetLowPrice": 10.0, "targetMeanPrice": 11.0, "targetMedianPrice": 11.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 17618000, "totalCashPerShare": 1.291, "ebitda": -44671332, "totalDebt": 0, "quickRatio": 1.529, "currentRatio": 1.796, "returnOnAssets": -1.01642, "returnOnEquity": -1701.5737, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ELTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Elicio Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1744415625, "regularMarketTime": 1744401601, "exchange": "NCM", "messageBoardId": "finmb_214936128", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.380674, "regularMarketPrice": 5.0, "marketState": "CLOSED", "longName": "Elicio Therapeutics, Inc.", "fiftyTwoWeekLowChange": 1.658, "fiftyTwoWeekLowChangePercent": 0.4961101, "fiftyTwoWeekRange": "3.342 - 11.45", "fiftyTwoWeekHighChange": -6.45, "fiftyTwoWeekHighChangePercent": -0.5633188, "fiftyTwoWeekChangePercent": -45.82882, "earningsTimestamp": 1743418800, "earningsTimestampStart": 1747133940, "earningsTimestampEnd": 1747656000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.25, "epsForward": -2.57, "epsCurrentYear": -2.4, "priceEpsCurrentYear": -2.0833333, "fiftyDayAverageChange": -2.6469002, "fiftyDayAverageChangePercent": -0.3461403, "twoHundredDayAverageChange": -0.64235497, "twoHundredDayAverageChangePercent": -0.11384519, "priceToBook": -4.8732944, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "postMarketChangePercent": -13.4, "postMarketPrice": 4.33, "postMarketChange": -0.67, "regularMarketChange": -0.07000017, "regularMarketDayRange": "5.0 - 5.2876", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 48015, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "displayName": "Elicio Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]